ImmunitoAI

AI-powered platform for efficient Antibody Drug Design

description

immunitoAI is a biotech startup that aims to make targeted therapy using antibodies a norm. It is developing an AI-powered platform for antibody discovery and screening. The platform screens and ranks the best antibody candidates for a given target/antigen. With this technology, the discovery process can be made 2x more efficient while improving the success rate.

founders

Aridni Shah
Trisha Chatterjee

founded

2020

year of investment

Sep 2021

"

why we invested

Antibodies are promising drug candidates but have a long, inefficient discovery and development process. Immunito is disrupting this space with their AI platform that generates novel antibodies for any given protein target.

"

Latest on

ImmunitoAI

September 21, 2021
ImmunitoAI: AI powered Antibody Discovery & Screening

More from the

folio

Alternative protein using precision fermentation
Life Sciences
Materials
AI chatbot providing accessible mental health therapy.
AI
AI assistant to streamline operations for small businesses
AI
Exited